BRCA2 Gene Mutation in Sisters with Ovarian Cancer
Author Information
Author(s): S Roth, P Kristol, A Auranen, M Shayeghi, S Seal, N Collins, R Barfoot, N Rahman, P J Klemi, S Gr6nman, L Sarantaus, H Nevanlinna, R ButZow, A Ashworth, MR Stratton, LA Aaltonen
Primary Institution: Haartman Institute, Department of Medical Genetics, University of Helsinki
Hypothesis
Is there a specific mutation in the BRCA2 gene that contributes to ovarian cancer in a Finnish family with three affected sisters?
Conclusion
The study identified a missense mutation in the BRCA2 gene that is likely associated with ovarian cancer in the three sisters.
Supporting Evidence
- The mutation was not found in 220 cancer-free Finnish controls.
- The mutation was present in all three sisters with ovarian cancer.
- Loss of heterozygosity was observed in one tumor sample from the sisters.
Takeaway
Three sisters in a family had ovarian cancer because of a change in a gene called BRCA2, which helps protect against cancer.
Methodology
The entire coding sequence of the BRCA2 gene was screened using conformation-sensitive gel electrophoresis and direct sequencing.
Limitations
The mutation's functional significance has not been evaluated, and the variant was not found in a large series of controls.
Participant Demographics
Three sisters from a Finnish family with a history of ovarian cancer.
Want to read the original?
Access the complete publication on the publisher's website